共 50 条
- [31] Efficacy and safety of a new generation von Willebrand factor/factor VIII concentrate (Wilate®) in the management of perioperative haemostasis in von Willebrand disease patients undergoing surgeryTHROMBOSIS AND HAEMOSTASIS, 2011, 105 (06) : 1072 - 1079Windyga, Jerzyvon Depka-Prondzinski, Mario
- [32] Continuous infusion of human plasma-derived von Willebrand factor concentrate as an effective therapy in a patient with acquired von Willebrand diseaseHAEMOPHILIA, 2014, 20 (06) : E411 - E414Patel, S. B.Rodgers, G. M.
- [33] The Empower Study - Design of a Randomized Clinical Trial to Assess the Efficacy and Safety of a Plasma-Derived Von Willebrand Factor / Factor VIII Concentrate for Heavy Menstrual Bleeding in Women with Von Willebrand DiseaseBLOOD, 2022, 140 : 8483 - 8484Sholzberg, MichelleTang, Grace H.James, Paula D.Meffe, FilomenaRimmer, EmilyJackson, ShannonSun, Haowei LindaRobinson, SueFloros, GeorginaAratia, ShamshahJuni, Peterda Costa, Bruno R.
- [34] TREATMENT WITH A PLASMA-DERIVED VON WILLEBRAND FACTOR (VWF) ALMOST DEVOID OF FACTOR VIII IN ELDERLY PATIENTS WITH VON WILLEBRAND DISEASE (VWD): A POOLED ANALYSISHAEMOPHILIA, 2022, 28 : 109 - 110Goudemand, J.Derlon, A. BorelHenriet, C.Susen, S.Repesse, Y.
- [35] TREATMENT WITH A PLASMA-DERIVED VON WILLEBRAND FACTOR (VWF) ALMOST DEVOID OF FACTOR VIII IN PAEDIATRIC PATIENTS WITH VON WILLEBRAND DISEASE (VWD): A POOLED ANALYSISHAEMOPHILIA, 2023, 29 : 147 - 147Goudemand, J.Borel-Derlon, A.Henriet, C.Repesse, Y.Susen, S.
- [36] Prospective, observational study of plasma-derived factor VIII/von Willebrand factor in immune tolerance induction: the PRISM registryHAEMOPHILIA, 2015, 21 (02) : E122 - E124Kruse-Jarres, R.Gilsenan, A.Spears, J.Kaye, J. A.
- [37] Clinical Efficacy and Safety of Fanhdi(R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective StudyCLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28Jimenez-Yuste, VictorTeresa Alvarez-Roman, MariaPalomo Bravo, AngelesGalmes, Bernardo J.Nieto Hernandez, Maria del MarBenitez Hidalgo, OlgaMarzo Alonso, CristinaPerez Gonzalez, Noelia FlorenciaColl, JuliaNunez, RamiroCarrasco, MarinaGarcia Candel, FaustinoRamon Gonzalez-Porras, JoseHernandez Garcia, CarmenVaro Castro, Maria JoseMir, Roser
- [38] Clinical Efficacy and Safety of Fanhdi((R)), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective StudyCLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28Jimenez-Yuste, VictorAlvarez-Roman, Maria TeresaPalomo Bravo, AngelesGalmes, Bernardo J.Nieto Hernandez, Maria del MarBenitez Hidalgo, OlgaMarzo Alonso, CristinaPerez Gonzalez, Noelia FlorenciaColl, JuliaNunez, RamiroCarrasco, MarinaGarcia Candel, FaustinoGonzalez-Porras, Jose RamonHernandez Garcia, CarmenVaro Castro, Maria JoseMir, Roser
- [39] Clinical Efficacy and Safety of Fanhdi (R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective StudyCLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28Jimenez-Yuste, VictorAlvarez-Roman, Maria TeresaBravo, Angeles PalomoGalmes, Bernardo J.Hernandez, Maria del Mar NietoHidalgo, Olga BenitezAlonso, Cristina MarzoGonzalez, Noelia Florencia PerezColl, JuliaNunez, RamiroCarrasco, MarinaCandel, Faustino GarciaGonzalez-Porras, Jose RamonGarcia, Carmen HernandezCastro, Maria Jose VaroMir, Roser
- [40] Long-Term Safety and Efficacy Data of a Plasma-Derived Factor VIII Concentrate with von Willebrand Factor for Treatment of Patients with Hemophilia A Covering 18 YearsHAMOSTASEOLOGIE, 2019, 39 (04): : 360 - 367Kittler, Sabine Friederike KarolinMiesbach, WolfgangBauhofer, ArturBecker, ThomasSchuettrumpf, JoergDubovy, PatrickNemes, LaszloRichter, HeinrichKoenigs, Christoph